{"log_id": 4560098715241374843, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0, "average": 0.952029, "min": 0.952029}, "location": {"width": 61, "top": 0, "height": 89, "left": 1146}, "words": "L"}, {"probability": {"variance": 1e-06, "average": 0.998643, "min": 0.9974}, "location": {"width": 90, "top": 117, "height": 26, "left": 177}, "words": "核准日期"}, {"probability": {"variance": 0, "average": 0.984155, "min": 0.984155}, "location": {"width": 35, "top": 115, "height": 31, "left": 1168}, "words": "局"}, {"probability": {"variance": 0, "average": 0.999219, "min": 0.998408}, "location": {"width": 92, "top": 165, "height": 27, "left": 176}, "words": "修改日期"}, {"probability": {"variance": 5.3e-05, "average": 0.995693, "min": 0.974487}, "location": {"width": 234, "top": 254, "height": 35, "left": 487}, "words": "注射用依那西普说明书"}, {"probability": {"variance": 4e-06, "average": 0.998771, "min": 0.991481}, "location": {"width": 388, "top": 302, "height": 41, "left": 399}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0, "average": 0.998474, "min": 0.99782}, "location": {"width": 48, "top": 400, "height": 26, "left": 215}, "words": "警告"}, {"probability": {"variance": 0, "average": 0.999573, "min": 0.998643}, "location": {"width": 91, "top": 449, "height": 25, "left": 216}, "words": "严重感染"}, {"probability": {"variance": 1e-06, "average": 0.999232, "min": 0.996815}, "location": {"width": 833, "top": 480, "height": 45, "left": 260}, "words": "使用恩利进行治疗的患者发生严重感染的风险增高,可能导致住院或死亡(见警告"}, {"probability": {"variance": 2.9e-05, "average": 0.99805, "min": 0.968375}, "location": {"width": 883, "top": 528, "height": 48, "left": 214}, "words": "和不良反应)。而绝大多数出现上述情况的患者同时合用免疫抑制剂,如甲氨蝶呤或皮质"}, {"probability": {"variance": 0, "average": 0.999522, "min": 0.999055}, "location": {"width": 49, "top": 598, "height": 26, "left": 214}, "words": "激素"}, {"probability": {"variance": 0.000134, "average": 0.994498, "min": 0.95431}, "location": {"width": 459, "top": 636, "height": 38, "left": 215}, "words": "一旦患者发生严重感染或脓毒血症应停用恩利"}, {"probability": {"variance": 0.000239, "average": 0.993271, "min": 0.95245}, "location": {"width": 185, "top": 692, "height": 31, "left": 215}, "words": "已报告的感染包括"}, {"probability": {"variance": 5e-06, "average": 0.998704, "min": 0.99}, "location": {"width": 844, "top": 726, "height": 46, "left": 254}, "words": "活动性结核感染,包括再活化的潜伏性结核感染。结核感染患者反复出现播散性或肺"}, {"probability": {"variance": 0.000107, "average": 0.996942, "min": 0.937917}, "location": {"width": 842, "top": 775, "height": 45, "left": 256}, "words": "外病变。患者使用恩利前和用药过程中,应检测潜伏性的结核感染。使用恩利治疗"}, {"probability": {"variance": 0, "average": 0.999736, "min": 0.997561}, "location": {"width": 305, "top": 834, "height": 35, "left": 255}, "words": "前必须治疗潜伏性的结核感染"}, {"probability": {"variance": 5e-06, "average": 0.998796, "min": 0.987952}, "location": {"width": 828, "top": 872, "height": 46, "left": 256}, "words": "侵袭性真菌感染,包括组织胞浆菌病,球孢子菌病,念珠菌病,曲霉病,芽生菌病"}, {"probability": {"variance": 5.5e-05, "average": 0.997597, "min": 0.955466}, "location": {"width": 846, "top": 921, "height": 46, "left": 256}, "words": "和肺孢子虫病。患者有组织胞浆菌病或其他侵袭性真菌感染者,可能呈现播散性而非"}, {"probability": {"variance": 2.2e-05, "average": 0.997742, "min": 0.975327}, "location": {"width": 844, "top": 970, "height": 45, "left": 257}, "words": "局限性病变。一些活动性感染患者的组织胞浆菌病的抗原和抗体检测可能为阴性。患"}, {"probability": {"variance": 1e-06, "average": 0.999259, "min": 0.994552}, "location": {"width": 848, "top": 1019, "height": 45, "left": 256}, "words": "者的侵袭性真菌感染有发展为严重全身性疾病风险时,应考虑给予经验性抗真菌治"}, {"probability": {"variance": 0, "average": 0.999587, "min": 0.999587}, "location": {"width": 25, "top": 1085, "height": 25, "left": 255}, "words": "疗"}, {"probability": {"variance": 0.044331, "average": 0.849391, "min": 0.551631}, "location": {"width": 125, "top": 1072, "height": 46, "left": 700}, "words": "药经资"}, {"probability": {"variance": 2e-05, "average": 0.998292, "min": 0.978566}, "location": {"width": 489, "top": 1120, "height": 41, "left": 256}, "words": "因机会致病菌导致的细菌性,病毒性和其他感染"}, {"probability": {"variance": 2.6e-05, "average": 0.997857, "min": 0.969964}, "location": {"width": 786, "top": 1165, "height": 44, "left": 257}, "words": "慢性或反复感染的患者使用恩利治疗之前,应当仔细评估其承担的风险和受益"}, {"probability": {"variance": 5.8e-05, "average": 0.998081, "min": 0.95292}, "location": {"width": 848, "top": 1214, "height": 45, "left": 258}, "words": "使用恩利治疗时和治疗后,应严密监测患者感染症状和体征的变化,包括那些治疗前"}, {"probability": {"variance": 1e-06, "average": 0.999289, "min": 0.996491}, "location": {"width": 624, "top": 1268, "height": 40, "left": 214}, "words": "的潜伏性结核感染检测结果呈阴性而可能发生结核感染的患者"}, {"probability": {"variance": 1e-06, "average": 0.99872, "min": 0.99727}, "location": {"width": 95, "top": 1375, "height": 28, "left": 212}, "words": "恶性肿瘤"}, {"probability": {"variance": 0.004977, "average": 0.986526, "min": 0.55848}, "location": {"width": 851, "top": 1411, "height": 43, "left": 255}, "words": "有报告使用TNF-拮抗剂,包括恩利,治疗的儿童和青少年患者发生淋巴瘤和其他恶"}, {"probability": {"variance": 0, "average": 0.999336, "min": 0.99852}, "location": {"width": 237, "top": 1472, "height": 29, "left": 212}, "words": "性肿瘤,有些是致命的"}, {"probability": {"variance": 1e-06, "average": 0.998991, "min": 0.996718}, "location": {"width": 139, "top": 1587, "height": 25, "left": 172}, "words": "版本号:20090"}, {"probability": {"variance": 9.5e-05, "average": 0.993751, "min": 0.970402}, "location": {"width": 166, "top": 1576, "height": 28, "left": 792}, "words": "第1页共31页"}], "language": 3}